Dong Song Wei
Segretario Aziendale presso SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.
Patrimonio netto: 29 397 $ in data 30/06/2024
Posizioni attive di Dong Song Wei
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Segretario Aziendale | 09/01/2012 | - |
| Corporate Officer/Principal | 18/08/2011 | 09/01/2012 | |
Sinopharm YiXin Pharmaceutical Co., Ltd.
 Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Dong Song Wei
Statistiche
Distribuzione geografica
| Cina | 3 |
Posizioni
| Corporate Officer/Principal | 1 |
| Corporate Secretary | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Sinopharm YiXin Pharmaceutical Co., Ltd.
Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Health Technology |
- Borsa valori
- Insiders
- Dong Song Wei
- Esperienza
